| Subscribe To Our Free Newsletter |
Mankind Pharma receives reaffirmation in credit rating from CRISIL
Commercial paper (Rs 5,000 crore) - CRISIL A1+
Non convertible debentures (Rs 4,600 crore) - CRISIL AA+/ Stable
Non convertible debentures (Rs 400 crore) - CRISIL AA+/ Stable
Total bank loan facilities rated (Rs 1,250 crore) - CRISIL AA+/ Stable
